These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

912 related items for PubMed ID: 8353921

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL.
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Thallium reinjection demonstrates viable myocardium in regions with reverse redistribution.
    Marin-Neto JA, Dilsizian V, Arrighi JA, Freedman NM, Perrone-Filardi P, Bacharach SL, Bonow RO.
    Circulation; 1993 Oct; 88(4 Pt 1):1736-45. PubMed ID: 8403320
    [Abstract] [Full Text] [Related]

  • 5. Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium.
    Dilsizian V, Freedman NM, Bacharach SL, Perrone-Filardi P, Bonow RO.
    Circulation; 1992 Feb; 85(2):627-34. PubMed ID: 1735157
    [Abstract] [Full Text] [Related]

  • 6. Differential uptake and apparent 201Tl washout after thallium reinjection. Options regarding early redistribution imaging before reinjection or late redistribution imaging after reinjection.
    Dilsizian V, Bonow RO.
    Circulation; 1992 Mar; 85(3):1032-8. PubMed ID: 1537101
    [Abstract] [Full Text] [Related]

  • 7. Thallium reinjection after stress-redistribution imaging. Does 24-hour delayed imaging after reinjection enhance detection of viable myocardium?
    Dilsizian V, Smeltzer WR, Freedman NM, Dextras R, Bonow RO.
    Circulation; 1991 Apr; 83(4):1247-55. PubMed ID: 2013145
    [Abstract] [Full Text] [Related]

  • 8. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.
    Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO.
    N Engl J Med; 1990 Jul 19; 323(3):141-6. PubMed ID: 2362606
    [Abstract] [Full Text] [Related]

  • 9. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects.
    Brunken RC, Mody FV, Hawkins RA, Nienaber C, Phelps ME, Schelbert HR.
    Circulation; 1992 Nov 19; 86(5):1357-69. PubMed ID: 1423947
    [Abstract] [Full Text] [Related]

  • 10. Thallium scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction.
    Marin-Neto JA, Dilsizian V, Arrighi JA, Perrone-Filardi P, Bacharach SL, Bonow RO.
    Am J Cardiol; 1998 Nov 01; 82(9):1001-7. PubMed ID: 9817471
    [Abstract] [Full Text] [Related]

  • 11. Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction.
    Perrone-Filardi P, Bacharach SL, Dilsizian V, Maurea S, Frank JA, Bonow RO.
    Circulation; 1992 Oct 01; 86(4):1125-37. PubMed ID: 1394920
    [Abstract] [Full Text] [Related]

  • 12. Comparison of rest-redistribution thallium-201 imaging and reinjection after stress-redistribution for the assessment of myocardial viability in patients with left ventricular dysfunction secondary to coronary artery disease.
    Galassi AR, Centamore G, Fiscella A, Coppola A, Liberti F, Franco M, Palazzo G, Musumeci S, Galassi A.
    Am J Cardiol; 1995 Mar 01; 75(7):436-42. PubMed ID: 7863985
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization?
    Kitsiou AN, Srinivasan G, Quyyumi AA, Summers RM, Bacharach SL, Dilsizian V.
    Circulation; 1998 Aug 11; 98(6):501-8. PubMed ID: 9714106
    [Abstract] [Full Text] [Related]

  • 15. Persistent twenty-four hour SPECT thallium-201 defects, plasma thallium-201 concentrations and PET metabolic viability.
    Brunken RC, Mody FV, Hawkins RA, Nienaber CA, Phelps ME, Schelbert HR.
    Herz; 1994 Feb 11; 19(1):28-41. PubMed ID: 8150412
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease.
    Perrone-Filardi P, Bacharach SL, Dilsizian V, Marin-Neto JA, Maurea S, Arrighi JA, Bonow RO.
    J Am Coll Cardiol; 1994 Mar 01; 23(3):608-16. PubMed ID: 8113542
    [Abstract] [Full Text] [Related]

  • 17. Thallium 201 for assessment of myocardial viability.
    Bonow RO, Dilsizian V.
    Semin Nucl Med; 1991 Jul 01; 21(3):230-41. PubMed ID: 1948113
    [Abstract] [Full Text] [Related]

  • 18. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
    Tamaki N, Ohtani H, Yonekura Y, Shindo M, Nohara R, Kambara H, Kawai C, Hirata K, Ban T, Konishi J.
    J Cardiol; 1992 Jul 01; 22(2-3):283-93. PubMed ID: 1339787
    [Abstract] [Full Text] [Related]

  • 19. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile.
    Cuocolo A, Pace L, Ricciardelli B, Chiariello M, Trimarco B, Salvatore M.
    J Nucl Med; 1992 Apr 01; 33(4):505-11. PubMed ID: 1552332
    [Abstract] [Full Text] [Related]

  • 20. Head-to-head comparison of 201Tl rest-redistribution scintigraphy and stress-immediate reinjection scintigraphy in the detection of myocardial viability.
    van Eck-Smit BL, van der Wall EE, Siebelink HM, Baur LH, Zwinderman AH, Pauwels EK.
    Nucl Med Commun; 1996 Mar 01; 17(3):216-24. PubMed ID: 8692489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.